Morning Market Movers (ITMN, BASI, NYMX, MI)

InterMune Inc ITMN jumped 101.89% to $28.81 at 10:24 am. The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has backed the ITMN's experimental lung drug Esbriet. Bioanalytical Systems Inc BASI climbed 40.00% to $2.52. BASI's shares have surged 71.43% over the past 52 weeks, while the S&P 500 index has gained 13.39% in the same period. Nymox Pharmaceutical Corporation NYMX shares advanced 29.82% to $5.79. NYMX licensed the European rights for the development and commercialization of its Phase III investigational drug NX-1207 to Recordati. Marshall & Ilsley Corp MI shares surged 18.83% to $6.88. BMO Financial Group BMO announced its plans to buy MI for $4.1 billion in an all-stock deal. Read more from Benzinga's Markets.